Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. 1998

E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
Basic Neuroscience Program, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, MD 20892-1430, USA.

A missense mutation in the human alpha synuclein gene was recently identified in some cases of familial Parkinson's disease (FPD). We have developed an antibody that recognizes the C-terminal 12 amino acids of the human alpha synuclein protein and have demonstrated that alpha synuclein is an abundant component of the Lewy bodies found within the degenerating neurons of patients with Parkinson's disease (PD). The presence of alpha synuclein in Lewy bodies of sporadic PD patients suggests a central role for alpha synuclein in the pathogenesis of PD.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010750 Phosphoproteins Phosphoprotein
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons

Related Publications

E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
April 1998, The American journal of pathology,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
September 1998, Experimental neurology,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
May 2000, Neurology,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
May 1998, Proceedings of the National Academy of Sciences of the United States of America,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
October 1999, Brain research,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
April 2000, Annals of neurology,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
August 1997, Nature,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
December 1999, Rinsho shinkeigaku = Clinical neurology,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
October 2010, Human molecular genetics,
E Mezey, and A M Dehejia, and G Harta, and N Tresser, and S F Suchy, and R L Nussbaum, and M J Brownstein, and M H Polymeropoulos
September 2000, Brain research,
Copied contents to your clipboard!